← Browse by Condition
Medical Condition

angioimmunoblastic t cell lymphoma refractory

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07058103 Phase 2
Recruiting

Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL

Enrollment
40 pts
Location
China
Sponsor
The Affiliated Hospital of Xuz...
View Trial →